# Investigation of photophysical properties and potential biological applications of substituted tris(polypyridyl)ruthenium(II) complexes

## TL;DR

This study explores a ruthenium complex's light-related properties and its potential use in cancer treatment and diagnostics.

## Contribution

The study introduces a substituted ruthenium complex with comparable anticancer and antioxidant properties to a known complex.

## Key findings

- The complex shows comparable anticancer and antioxidant potential to [Ru(bpy)3]2+.
- Its properties depend on ligand nature and the medium of investigation.
- It can bind with quinones, suggesting potential as a bioanalyte.

## Abstract

The photophysical properties of tris(polypyridyl)ruthenium(II) complex [Ru(dmbpy)3]2+ [dmbpy = 4,4′-dimethyl-2,2′-bipyridine] were investigated and compared with [Ru(bpy)3]2+ following both experimental and computational approaches. The variations in the electronic properties of the complex in the ground and excited states were determined by density functional theory (DFT) methods, and their effects on the anticancer, antioxidant, and antimicrobial activities were also evaluated by molecular docking and dynamic simulation studies. The potential of these complexes to serve as bioanalytes was investigated by their ability to bind with quinones, the well-known electron mediators in numerous light-driven reactions. Following the above, the anticancer properties were evaluated against breast cancer-related proteins. The results revealed that the complex possesses comparable anticancer and antioxidant potential to that of [Ru(bpy)3]2+. The physical, electronic, and biological properties of this complex depend on the nature of the ligands and the medium of investigation. Herein, the potential applications of [Ru(bpy)3]2+ in clinical diagnostics as antioxidants and therapeutic agents were evaluated.